Source:http://linkedlifedata.com/resource/pubmed/id/11964926
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2002-4-19
|
| pubmed:abstractText |
Laboratory data suggest that the cholesterol-lowering "statin" drugs may have chemopreventive potential against cancer at various sites, including breast and prostate. However, in one trial of pravastatin there was a significant excess of breast cancer in the treatment group. In the present study, we assessed the relation of statin use to the risk of breast and prostate cancer in our hospital-based Case-Control Surveillance Study of Drugs and Serious Illnesses.
|
| pubmed:grant | |
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
1044-3983
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
13
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
262-7
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:11964926-Aged,
pubmed-meshheading:11964926-Breast Neoplasms,
pubmed-meshheading:11964926-Female,
pubmed-meshheading:11964926-Humans,
pubmed-meshheading:11964926-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:11964926-Male,
pubmed-meshheading:11964926-Middle Aged,
pubmed-meshheading:11964926-Odds Ratio,
pubmed-meshheading:11964926-Prostatic Neoplasms,
pubmed-meshheading:11964926-United States
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
Statin use and the risk of breast and prostate cancer.
|
| pubmed:affiliation |
Slone Epidemiology Unit, Boston University School of Medicine, Brookline, MA 02446, USA. pcoogan@slone.bu.edu
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|